Threshold for calcium volume evaluation in patients with aortic valve stenosis: correlation with Agatston score.


Journal

Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752

Informations de publication

Date de publication:
01 06 2021
Historique:
pubmed: 6 12 2020
medline: 28 12 2021
entrez: 5 12 2020
Statut: ppublish

Résumé

The evaluation of aortic valve calcium burden is important when planning for transcatheter aortic valve implantation (TAVI). Although a robust golden standard methodology is available for calcium evaluation on noncontrast-enhanced (NCE) computed tomographic (CT) series, a standard reference for calcium assessment on contrast-enhanced CT series is currently lacking. Two hundred and forty-four preprocedural CT scans from patients who had received TAVI were analysed. We correlated the aortic calcium volumes obtained on CE series at three thresholds [450, 850, and 'probe + 100' Hounsfield Units (HU)] with the Agatston score obtained on NCE scans. A subgroup analysis was performed taking into account the contrast enhancement of the left ventricular outflow tract (LVOT), with a prespecified cut-off of 300 HU. The overall population analysis showed higher correlation with the Agatston score using the 850 HU threshold (r = 0.45, P < 0.0001); no correlation was found with the 450 HU threshold, whilst the 'probe + 100' HU threshold showed a weaker correlation (r = 0.30, P < 0.0001). In patients with LVOT enhancement less than 300 HU, 450 HU showed the highest accuracy in calcium identification (r = 0.70, P < 0.0001), whereas in patients with LVOT enhancement of at least 300 HU, the most accurate threshold was 850 HU (r = 0.46, P < 0.0001). The thresholds for correct calcium identification using the automatic 3Mensio software depend on the contrast enhancement of aortic and cardiac structures, which can be estimated by measuring the HU in the LVOT. In patients with LVOT HU of less than 300, the correct threshold to be set in the software is 450 HU, whereas in patients with LVOT HU of at least 300 the correct threshold is 850 HU.

Sections du résumé

BACKGROUND
The evaluation of aortic valve calcium burden is important when planning for transcatheter aortic valve implantation (TAVI). Although a robust golden standard methodology is available for calcium evaluation on noncontrast-enhanced (NCE) computed tomographic (CT) series, a standard reference for calcium assessment on contrast-enhanced CT series is currently lacking.
METHODS
Two hundred and forty-four preprocedural CT scans from patients who had received TAVI were analysed. We correlated the aortic calcium volumes obtained on CE series at three thresholds [450, 850, and 'probe + 100' Hounsfield Units (HU)] with the Agatston score obtained on NCE scans. A subgroup analysis was performed taking into account the contrast enhancement of the left ventricular outflow tract (LVOT), with a prespecified cut-off of 300 HU.
RESULTS
The overall population analysis showed higher correlation with the Agatston score using the 850 HU threshold (r = 0.45, P < 0.0001); no correlation was found with the 450 HU threshold, whilst the 'probe + 100' HU threshold showed a weaker correlation (r = 0.30, P < 0.0001). In patients with LVOT enhancement less than 300 HU, 450 HU showed the highest accuracy in calcium identification (r = 0.70, P < 0.0001), whereas in patients with LVOT enhancement of at least 300 HU, the most accurate threshold was 850 HU (r = 0.46, P < 0.0001).
CONCLUSION
The thresholds for correct calcium identification using the automatic 3Mensio software depend on the contrast enhancement of aortic and cardiac structures, which can be estimated by measuring the HU in the LVOT. In patients with LVOT HU of less than 300, the correct threshold to be set in the software is 450 HU, whereas in patients with LVOT HU of at least 300 the correct threshold is 850 HU.

Identifiants

pubmed: 33278208
pii: 01244665-202106000-00010
doi: 10.2459/JCM.0000000000001145
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

496-502

Informations de copyright

Copyright © 2020 Italian Federation of Cardiology - I.F.C. All rights reserved.

Références

Baumgartner H, Falk V, Bax JJ, et al. ESC Scientific Document Group. Group, E. S. D., 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38:2739–2791.
Blanke P, Weir-McCall JR, Achenbach S, et al. Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI) /transcatheter aortic valve replacement (TAVR): an expert consensus document of the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr 2019; 13:1–20.
Ewe SH, Ng AC, Schuijf JD, et al. Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation. Am J Cardiol 2011; 108:1470–1477.
Schultz C, Rossi A, van Mieghem N, et al. Aortic annulus dimensions and leaflet calcification from contrast MSCT predict the need for balloon postdilatation after TAVI with the Medtronic CoreValve prosthesis. EuroIntervention 2011; 7:564–572.
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827–832.
Messika-Zeitoun D, Aubry MC, Detaint D, et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation 2004; 110:356–362.
Bettinger N, Khalique OK, Krepp JM, et al. Practical determination of aortic valve calcium volume score on contrast-enhanced computed tomography prior to transcatheter aortic valve replacement and impact on paravalvular regurgitation: elucidating optimal threshold cutoffs. J Cardiovasc Comput Tomogr 2017; 11:302–308.
Jilaihawi H, Makkar RR, Kashif M, et al. A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 2014; 15:1324–1332.
Kizer JR, Gefter WB, deLemos AS, Scoll BJ, Wolfe ML, Mohler ER 3rd. Electron beam computed tomography for the quantification of aortic valvular calcification. J Heart Valve Dis 2001; 10:361–366.
Akodad M, Lattuca B, Agullo A, et al. Prognostic impact of calcium score after transcatheter aortic valve implantation performed with new generation prosthesis. Am J Cardiol 2018; 121:1225–1230.
Kong WK, van Rosendael PJ, van der Kley F, et al. Impact of different iterations of devices and degree of aortic valve calcium on paravalvular regurgitation after transcatheter aortic valve implantation. Am J Cardiol 2016; 118:567–571.
Bekeredjian R, Bodingbauer D, Hofmann NP, et al. The extent of aortic annulus calcification is a predictor of postprocedural eccentricity and paravalvular regurgitation: a pre and postinterventional cardiac computed tomography angiography study. J Invasive Cardiol 2015; 27:172–180.
Eberhard M, Hinzpeter R, Polacin M, et al. Reproducibility of aortic valve calcification scoring with computed tomography: an interplatform analysis. J Cardiovasc Comput Tomogr 2019; 13:92–98.
Maeno Y, Abramowitz Y, Kawamori H, et al. A highly predictive risk model for pacemaker implantation after TAVR. JACC Cardiovasc Imaging 2017; 10 (10 Pt A):1139–1147.
Eberhard M, Mastalerz M, Frauenfelder T, et al. Quantification of aortic valve calcification on contrast-enhanced CT of patients prior to transcatheter aortic valve implantation. EuroIntervention 2017; 13:921–927.
Kim WK, Renker M, Rolf A, et al. Accuracy of device landing zone calcium volume measurement with contrast-enhanced multidetector computed tomography. Int J Cardiol 2018; 263:171–176.

Auteurs

Marco Angelillis (M)

Cardiothoracic and Vascular Department, University Hospital Pisa, Italy.

Giulia Costa (G)

Cardiothoracic and Vascular Department, University Hospital Pisa, Italy.

Ole De Backer (O)

The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Veronica Mochi (V)

Cardiothoracic and Vascular Department, University Hospital Pisa, Italy.

Andrea Christou (A)

Cardiothoracic and Vascular Department, University Hospital Pisa, Italy.

Cristina Giannini (C)

Cardiothoracic and Vascular Department, University Hospital Pisa, Italy.

Paolo Spontoni (P)

Cardiothoracic and Vascular Department, University Hospital Pisa, Italy.

Marco De Carlo (M)

Cardiothoracic and Vascular Department, University Hospital Pisa, Italy.

Lars Søndergaard (L)

The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Mario Miccoli (M)

Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Anna S Petronio (AS)

Cardiothoracic and Vascular Department, University Hospital Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH